Five miRNAs (miR-616, miR-646, miR-554, miR-3529-5p and miR-23a) were predicted in silico to inhibit TFPI2 translation in tumor-associated fibroblast based on different miR databases. The gene discussed is TFPI2; the disease is neoplasm.